J. Hickling

发表

Improving the affordability of inactivated poliovirus vaccines (IPV) for use in low- and middle-income countries. An economic analysis of strategies to reduce the cost of routine IPV immunization.

J. Hickling, R. Jones, N. Nundy, 2010 .

Meeting report: Initial World Health Organization consultation on herpes simplex virus (HSV) vaccine preferred product characteristics, March 2017.

C. Deal, D. Kaslow, J. Hickling, 2017, Vaccine.

Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23-24 August 2016.

S. Madhi, D. Spiro, G. Rimmelzwaan, 2018, Vaccine.

Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens.

S. H. van der Burg, R. Offringa, C. Melief, 2001, Vaccine.

Strategies for studying mouse and human immune responses to human papillomavirus type 16.

B. Chain, J. Hickling, K. Vousden, 1994, Ciba Foundation symposium.

Peptides recognized by class I restricted T cells also bind to MHC class II molecules.

J. Rothbard, J. Hickling, S. Marsh, 1990, International immunology.

Measuring human T-lymphocyte function

J. Hickling, Julian K. Hickling, 1998, Expert Reviews in Molecular Medicine.

Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5-7 May 2014.

N. Cox, G. Rimmelzwaan, J. Hickling, 2015, Vaccine.

Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial

A. Wheatley, J. Hickling, S. Rockman, 2020, PLoS medicine.

Effect of TA-CIN (HPV 16 L2E6E7) booster immunisation in vulval intraepithelial neoplasia patients previously vaccinated with TA-HPV (vaccinia virus encoding HPV 16/18 E6E7).

H. Kitchener, P. Stern, M. Pawlita, 2004, Vaccine.

Human T cell responses to human papillomavirus type 16 L1 and E6 synthetic peptides: identification of T cell determinants, HLA-DR restriction and virus type specificity.

J. Rothbard, J. Hickling, G. Strang, 1990, The Journal of general virology.

Human Cytotoxic T Cell Epitopes in HPV 11: Relationships between Allele-Specific Motifs, HLA Binding, and Stimulation in Vitro

S. Stacey, J. Hickling, A. Renton, 1994 .

Cellular responses at the application site of a high-density microarray patch delivering an influenza vaccine in a randomized, controlled phase I clinical trial

J. Hickling, S. Rockman, M. Veitch, 2021, PloS one.

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer

S. Stacey, A. Fiander, G. Wilkinson, 1996, The Lancet.

Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.

H. Kitchener, S. Stacey, T. Bauknecht, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer

J. Hickling, K. Vousden, N. Rolley, 1996, Vaccine.

Immunological Responses in Women with Human Papillomavirus Type 16 (HPV-16)-Associated Anogenital Intraepithelial Neoplasia Induced by Heterologous Prime-Boost HPV-16 Oncogene Vaccination

S. H. van der Burg, H. Kitchener, R. Offringa, 2004, Clinical Cancer Research.

Thermostable formulations of a hepatitis B vaccine and a meningitis A polysaccharide conjugate vaccine produced by a spray drying method.

M. Lal, J. Hickling, D. Kristensen, 2010, Vaccine.

Human cytomegalovirus‐specific cytotoxic T cells: their precursor frequency and stage specificity

J. Sissons, J. Hickling, L. Borysiewicz, 1988, European journal of immunology.

Polyclonal in vitro proliferative responses from nonimmune donors to Plasmodium falciparum malaria antigens require UCHL1+ (memory) T cells*

J. Hickling, J. Playfair, G. Targett, 1990, European journal of immunology.

Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses

J. Sissons, J. Hickling, J. Sinclair, 1988, The Journal of experimental medicine.

Intradermal delivery of vaccines: potential benefits and current challenges.

J. Hickling, Dexiang Chen, D. Kristensen, 2011, Bulletin of the World Health Organization.

Yellow fever vaccination: The potential of dose-sparing to increase vaccine supply and availability.

J. Hickling, R. Jones, 2013 .

Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22–23 March 2017

M. Jit, B. Blomberg, J. Hickling, 2018, Vaccine.

Varicella-zoster virus-specific cytotoxic T lymphocytes (Tc): detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood

J. Sissons, J. Hickling, L. Borysiewicz, 1987, Journal of virology.

Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia.

S. H. van der Burg, R. Offringa, M. Stanley, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.

H. Kitchener, P. Stern, M. Pawlita, 2003, Cancer research.

Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine.

S. H. van der Burg, R. Offringa, J. Hickling, 2002, Vaccine.

Human cytotoxic T lymphocytes stimulated by endogenously processed human papillomavirus type 11 E7 recognize a peptide containing a HLA-A2 (A*0201) motif.

S. Stacey, J. Hickling, A. Renton, 1994, Immunology.

High Degeneracy of HLA DR-Peptide Interactions: Possible Ramifications for Vaccine Design

Robert Busch, J. Rothbard, J. Hickling, 1989 .

Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™).

I. Frazer, J. Hickling, S. Rockman, 2018, Vaccine.

Generation of a primary immune response to a genetically inactivated (DISC) herpes simplex virus and wild type virus.

P. Ricciardi-Castagnoli, J. Hickling, M. Boursnell, 1997, Biochemical Society transactions.

A method for rapid screening of recombinant proteins for recognition by T lymphocytes

J. Rothbard, J. Hickling, K. R. Jones, 1992, European journal of immunology.

Thermostable formulations of a hepatitis B vaccine and a meningitis A polysaccharide conjugate vaccine produced by a spray drying method.

J. Hickling, D. Kristensen, S. Kapre, 2010, Vaccine.

Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™).

I. Frazer, J. Hickling, S. Rockman, 2018, Vaccine.